Consistently, similar tendency was obtained when examining the effect of CSAG2 knockdown on CPEB4-mediated advantages for colony formation (Figure 5D), further strengthening the notion that CSAG2 at least in part contributes to CPEB4-mediated paclitaxel resistance in ovarian cancer. Here, CPEB4 is linked to ovarian carcinoma.